Key topics in this newsletter include: A commercialisation update on the Company’s O2Vent sleep treatment platform for patients with Obstructive Sleep Apnoea, which includes an overview of the ‘lab in lab’ business model workflow; Oventus’ consumer education program through AwakeXpress.com; An update on the CRC-P Federal grant...
For more information, download the attached PDF.
Download this document
